Cargando…

Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases

Detalles Bibliográficos
Autores principales:	Yang, Haitao, Xie, Weiqing, Xue, Xiaoyu, Yang, Kailin, Ma, Jing, Liang, Wenxue, Zhao, Qi, Zhou, Zhe, Pei, Duanqing, Ziebuhr, John, Hilgenfeld, Rolf, Yuen, Kwok Yung, Wong, Luet, Gao, Guangxia, Chen, Saijuan, Chen, Zhu, Ma, Dawei, Bartlam, Mark, Rao, Zihe
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2005
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283410/ http://dx.doi.org/10.1371/journal.pbio.0030428

Ejemplares similares

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Coronavirus main proteinase: target for antiviral drug therapy
por: Anand, Kanchan, et al.
Publicado: (2005)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Crystal Structure of Human Coronavirus NL63 Main Protease in Complex With an Inhibitor
por: Yang, Kailin, et al.
Publicado: (2015)

An efficient and tunable route to AG7088, a rhinovirus protease inhibitor
por: Ma, Dawei, et al.
Publicado: (2004)

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
por: Cui, Wen, et al.
Publicado: (2020)

Production of Authentic SARS-CoV M(pro) with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein Overproduction
por: Xue, Xiaoyu, et al.
Publicado: (2007)

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design
por: Wang, Fenghua, et al.
Publicado: (2016)

Erratum to: Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode
por: Chen, Shuai, et al.
Publicado: (2010)

Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2
por: Zhao, Yao, et al.
Publicado: (2022)

Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
por: Zhu, Lili, et al.
Publicado: (2011)

Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
por: Anand, Kanchan, et al.
Publicado: (2002)

Structural insights into SARS coronavirus proteins
por: Bartlam, Mark, et al.
Publicado: (2005)

Preliminary crystallographic analysis of avian infectious bronchitis virus main protease
por: Li, Jun, et al.
Publicado: (2006)

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease †
por: Göhl, Matthias, et al.
Publicado: (2022)

Structure and Cleavage Specificity of the Chymotrypsin-Like Serine Protease (3CLSP/nsp4) of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
por: Tian, Xinsheng, et al.
Publicado: (2009)

Structure and Dynamics of Sars Coronavirus Main Proteinase (M(PRO))
por: Hilgenfeld, Rolf, et al.
Publicado: (2006)

Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
por: Zhang, Linlin, et al.
Publicado: (2021)

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021)

Identification of a Dual Inhibitor of Secreted Phospholipase A(2) (GIIA sPLA(2)) and SARS-CoV-2 Main Protease
por: Theodoropoulou, Maria A., et al.
Publicado: (2022)

H172Y mutation perturbs the S1 pocket and nirmatrelvir binding of SARS-CoV-2 main protease through a nonnative hydrogen bond
por: de Oliveira, Vinicius Martins, et al.
Publicado: (2022)

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
por: Zhang, Linlin, et al.
Publicado: (2020)

An Integrative Approach to Dissect the Drug Resistance Mechanism of the H172Y Mutation of SARS-CoV-2 Main Protease
por: Clayton, Joseph, et al.
Publicado: (2023)

Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variants
por: Lin, Mengmeng, et al.
Publicado: (2023)

Non Structural Proteins 8 and 9 of Human Coronavirus 229E
por: Ponnusamy, Rajesh, et al.
Publicado: (2006)

Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin
por: Lei, Jian, et al.
Publicado: (2016)

Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
por: Lei, Jian, et al.
Publicado: (2014)

The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor
por: Cui, Wen, et al.
Publicado: (2019)

Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease
por: Cooper, Mark S., et al.
Publicado: (2022)

Crystallization and preliminary crystallographic study of Feline infectious peritonitis virus main protease in complex with an inhibitor
por: Wang, Jinshan, et al.
Publicado: (2014)

Crystallization and preliminary crystallographic study of Porcine epidemic diarrhea virus main protease in complex with an inhibitor
por: Tan, Yusheng, et al.
Publicado: (2014)

High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
por: Zang, Yi, et al.
Publicado: (2022)

A Structural View of the Inactivation of the SARS Coronavirus Main Proteinase by Benzotriazole Esters
por: Verschueren, Koen H.G., et al.
Publicado: (2008)

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
por: Dai, Wenhao, et al.
Publicado: (2020)

pH-dependent Conformational Flexibility of the SARS-CoV Main Proteinase (M(pro)) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses
por: Tan, Jinzhi, et al.
Publicado: (2005)

Crystallization and preliminary crystallographic study of human coronavirus NL63 main protease in complex with an inhibitor
por: Wang, Fenghua, et al.
Publicado: (2014)

The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals
por: Wang, Fenghua, et al.
Publicado: (2022)

The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2
por: Jin, Zhenming, et al.
Publicado: (2021)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Characterization of SARS‐CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence‐based assay
por: Kao, Richard Y., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_hr30pjlc8km9gqci37qpijbau4